Clinical Trial Update: Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating pegaptanib for retinal edema due to diabetic vascular disease (diabetic macular edema); study completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Pegaptanib (Pegaptanib sodium)

Snippet

Sponsor: Valley Retina Institute | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED | Results posted: 2013-07-16